219 related articles for article (PubMed ID: 20846027)
1. Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage.
Medvedev SP; Grigor'eva EV; Shevchenko AI; Malakhova AA; Dementyeva EV; Shilov AA; Pokushalov EA; Zaidman AM; Aleksandrova MA; Plotnikov EY; Sukhikh GT; Zakian SM
Stem Cells Dev; 2011 Jun; 20(6):1099-112. PubMed ID: 20846027
[TBL] [Abstract][Full Text] [Related]
2. Neural stem cells differentiated from iPS cells spontaneously regain pluripotency.
Choi HW; Kim JS; Choi S; Hong YJ; Kim MJ; Seo HG; Do JT
Stem Cells; 2014 Oct; 32(10):2596-604. PubMed ID: 24898298
[TBL] [Abstract][Full Text] [Related]
3. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
5. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
[TBL] [Abstract][Full Text] [Related]
6. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of Odontoblast-Like Cells From Mouse Induced Pluripotent Stem Cells by Pax9 and Bmp4 Transfection.
Seki D; Takeshita N; Oyanagi T; Sasaki S; Takano I; Hasegawa M; Takano-Yamamoto T
Stem Cells Transl Med; 2015 Sep; 4(9):993-7. PubMed ID: 26136503
[TBL] [Abstract][Full Text] [Related]
8. Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system.
Lu HE; Tsai MS; Yang YC; Yuan CC; Wang TH; Lin XZ; Tseng CP; Hwang SM
Exp Cell Res; 2011 Aug; 317(13):1895-903. PubMed ID: 21640101
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
[TBL] [Abstract][Full Text] [Related]
10. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
11. Mouse-induced pluripotent stem cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for ischemic stroke therapy.
Liu SP; Fu RH; Wu DC; Hsu CY; Chang CH; Lee W; Lee YD; Liu CH; Chien YJ; Lin SZ; Shyu WC
Stem Cells Dev; 2014 Feb; 23(4):421-33. PubMed ID: 24266622
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cells.
Wang WW; Wang W; Jiang Y; Han GF; Lu S; Li G; Zhang J
Cytotherapy; 2013 May; 15(5):578-85. PubMed ID: 23415920
[TBL] [Abstract][Full Text] [Related]
13. Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
Song B; Sun G; Herszfeld D; Sylvain A; Campanale NV; Hirst CE; Caine S; Parkington HC; Tonta MA; Coleman HA; Short M; Ricardo SD; Reubinoff B; Bernard CC
Stem Cell Res; 2012 Mar; 8(2):259-73. PubMed ID: 22265745
[TBL] [Abstract][Full Text] [Related]
14. Generation of pig induced pluripotent stem cells using an extended pluripotent stem cell culture system.
Xu J; Yu L; Guo J; Xiang J; Zheng Z; Gao D; Shi B; Hao H; Jiao D; Zhong L; Wang Y; Wu J; Wei H; Han J
Stem Cell Res Ther; 2019 Jun; 10(1):193. PubMed ID: 31248457
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming of adult human neural stem cells into induced pluripotent stem cells.
Xie LQ; Sun HP; Wang T; Tang HL; Wang P; Zhu JH; Yao ZW; Feng XY
Chin Med J (Engl); 2013 Mar; 126(6):1138-43. PubMed ID: 23506594
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
Eminli S; Utikal J; Arnold K; Jaenisch R; Hochedlinger K
Stem Cells; 2008 Oct; 26(10):2467-74. PubMed ID: 18635867
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.
Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ
Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940
[TBL] [Abstract][Full Text] [Related]
18. Oct4-induced pluripotency in adult neural stem cells.
Kim JB; Sebastiano V; Wu G; Araúzo-Bravo MJ; Sasse P; Gentile L; Ko K; Ruau D; Ehrich M; van den Boom D; Meyer J; Hübner K; Bernemann C; Ortmeier C; Zenke M; Fleischmann BK; Zaehres H; Schöler HR
Cell; 2009 Feb; 136(3):411-9. PubMed ID: 19203577
[TBL] [Abstract][Full Text] [Related]
19. High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.
Liu T; Zou G; Gao Y; Zhao X; Wang H; Huang Q; Jiang L; Guo L; Cheng W
Stem Cells Dev; 2012 Aug; 21(12):2322-32. PubMed ID: 22264161
[TBL] [Abstract][Full Text] [Related]
20. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells.
Chang CW; Lai YS; Pawlik KM; Liu K; Sun CW; Li C; Schoeb TR; Townes TM
Stem Cells; 2009 May; 27(5):1042-9. PubMed ID: 19415770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
